Healthcare Triangle, Inc (HCTI) launches QuantumNexis subsidiary

Healthcare Triangle Inc. (NASDAQ: HCTI) officially launched its new subsidiary, QuantumNexis, on June 16, 2025 , at an exclusive, invite-only event at the Park Royal Collection Hotel in Kuala Lumpur. This milestone reinforces HCTIs commitment to advancing AI-powered digital healthcare platforms that meet the evolving demands of the global healthcare landscape.

QuantumNexis , positioned as The Future of Healthcare, Powered by Quantum Intelligence is a Generative AI-powered SaaS Solutions for the global healthcare market. By integrating cloud-native infrastructure, automation, and AI, QuantumNexis will serve as the innovative engine for HCTIs recurring revenue business lines.

The QuantumNexis portfolio includes:

Ziloy (www.ziloy.ai) - An AI-enabled mental wellness platform offering holistic, personalized behavioral health support.

Ezovion (www.ezovion.ai) - An innovative Hospital Information Management . System (HIMS) designed to digitize workflows and transform hospital operations.

Sujatha Ramesh, COO of HCTI said: QuantumNexis is a giant leap forward in AI-driven healthcare, because it leverages advanced machine learning capabilities, and predictive analytics. QuantumNexis empowers healthcare providers with actionable insights that enable faster diagnoses, improves patient outcomes, and delivers operational efficiency, she added.

QuantumNexisnew revenue streams will add strong strategic and financial value to HCTI, said David Ayanoglou, CFO, HCTI. It enhances our positioning in the rapidly evolving digital healthcare landscape, while creating massive public impact in underserved markets, he said.

Launching in Southeast Asia reinforces QuantumNexis international strategy and responds to strong demand for digital health modernization in high-growth markets. Backed by HCTIs regulatory expertise and enterprise-grade technology, QuantumNexis is set to scale globally.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Nu Skin EVP of global sales takes medical leave
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders